Award recordCONTRACT

OTSUKA AMERICA PHARMACEUTICAL INC

PIID 36C26024F0034· VHA· 260-NETWORK CONTRACT OFFICE 20 (36C260)· 6505 · DRUGS AND BIOLOGICALS· FY2024· $362,719 net obligations· UEI QKABLBMA8FT9· MD

Description

JYNARQUE INCREASE

Base award description: JYNARQUE

First action · last action
2023-10-01 · 2024-07-24
Transactions
3
First transaction's obligation
$317,589
Base + all options value (sum of deltas)
$362,719
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
—
Offers received
1
SDVOSB flag on record
No
Parent IDV
36F79720D0099
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 3 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$362,719$0Base award · 2023-10-01 · this action $317,589 · running total $317,589Modification P00001 · 2024-02-26 · this action $7,367 · running total $324,956Modification P00002 · 2024-07-24 · this action $37,763 · running total $362,719
  • Base2023-10-01+$317,589= $317,589
  • Mod P000012024-02-26+$7,367= $324,956
  • Mod P000022024-07-24+$37,763= $362,719
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2023-10-01+$317,589$317,589JYNARQUE
Mod P00001· FUNDING ONLY ACTION2024-02-26+$7,367$324,956JYNARQUE
Mod P00002· FUNDING ONLY ACTION2024-07-24+$37,763$362,719JYNARQUE INCREASE

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI QKABLBMA8FT9)

AwardOffice · PSC / listingNet obligationsFY
36C24526N0783245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS$20,378FY2026
36C24525N0988245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS$13,243FY2025
36C24525N0987245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS$13,168FY2025
36C24525N0901245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS$13,168FY2025
36C24525N0789245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS$13,168FY2025
36C24525N0683245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS$13,168FY2025

Other recipients under 6505 from 260-NETWORK CONTRACT OFFICE 20 (36C260) (most recent first)

AwardRecipientOfficeNet obligationsFY
36C26026F0379COSETTE PHARMACEUTICALS, INC.260-NETWORK CONTRACT OFFICE 20 (36C260)$3,466FY2026
36C26026P0671MCKESSON PLASMA AND BIOLOGICS LLC260-NETWORK CONTRACT OFFICE 20 (36C260)$18,262FY2026
36C26026F0349AGIOS PHARMACEUTICALS, INC.260-NETWORK CONTRACT OFFICE 20 (36C260)$73,080FY2026
36C26026F0306BRACCO DIAGNOSTICS INC.260-NETWORK CONTRACT OFFICE 20 (36C260)$337,422FY2026
36C26026F0298PROGENICS PHARMACEUTICALS INC260-NETWORK CONTRACT OFFICE 20 (36C260)$469,134FY2026

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C26024F0034_3600_36F79720D0099_3600 · retrieved 2026-09-26.